These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 8622964)

  • 21. Inhibition of glycosaminoglycan synthesis and protein glycosylation with WAS-406 and azaserine result in reduced islet amyloid formation in vitro.
    Hull RL; Zraika S; Udayasankar J; Kisilevsky R; Szarek WA; Wight TN; Kahn SE
    Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1586-93. PubMed ID: 17804609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid formation results in recurrence of hyperglycaemia following transplantation of human IAPP transgenic mouse islets.
    Udayasankar J; Kodama K; Hull RL; Zraika S; Aston-Mourney K; Subramanian SL; Tong J; Faulenbach MV; Vidal J; Kahn SE
    Diabetologia; 2009 Jan; 52(1):145-53. PubMed ID: 19002432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in amyloid deposition in islets of transgenic mice expressing human islet amyloid polypeptide versus human islets implanted into nude mice.
    Westermark G; Westermark P; Eizirik DL; Hellerström C; Fox N; Steiner DF; Andersson A
    Metabolism; 1999 Apr; 48(4):448-54. PubMed ID: 10206436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity: Implications for type 2 diabetes and islet transplantation.
    Park YJ; Warnock GL; Ao Z; Safikhan N; Meloche M; Asadi A; Kieffer TJ; Marzban L
    Diabetes Obes Metab; 2017 May; 19(5):682-694. PubMed ID: 28058779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human islet amyloid polypeptide transgenic mice as a model of non-insulin-dependent diabetes mellitus (NIDDM).
    Fox N; Schrementi J; Nishi M; Ohagi S; Chan SJ; Heisserman JA; Westermark GT; Leckström A; Westermark P; Steiner DF
    FEBS Lett; 1993 May; 323(1-2):40-4. PubMed ID: 8495745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of apolipoprotein E deficiency on islet amyloid deposition in human islet amyloid polypeptide transgenic mice.
    Vidal J; Verchere CB; Andrikopoulos S; Wang F; Hull RL; Cnop M; Olin KL; LeBoeuf RC; O'Brien KD; Chait A; Kahn SE
    Diabetologia; 2003 Jan; 46(1):71-9. PubMed ID: 12637985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Islet amyloid polypeptide in pancreatic islets from type 2 diabetic subjects.
    Tomita T
    Islets; 2012; 4(3):223-32. PubMed ID: 22847497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.
    Westermark P; Andersson A; Westermark GT
    Physiol Rev; 2011 Jul; 91(3):795-826. PubMed ID: 21742788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Islet amyloid polypeptide in proliferating pancreatic B cells during development, hyperplasia, and neoplasia in humans and mice.
    Rindi G; Terenghi G; Westermark G; Westermark P; Moscoso G; Polak JM
    Am J Pathol; 1991 Jun; 138(6):1321-34. PubMed ID: 1647136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic stress, IAPP and islet amyloid.
    Montane J; Klimek-Abercrombie A; Potter KJ; Westwell-Roper C; Bruce Verchere C
    Diabetes Obes Metab; 2012 Oct; 14 Suppl 3():68-77. PubMed ID: 22928566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Islet amyloid in type 2 (non-insulin-dependent) diabetes.
    Clark A; Chargé SB; Badman MK; de Koning EJ
    APMIS; 1996 Jan; 104(1):12-8. PubMed ID: 8645452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IAPP/amylin transgenic mice as an in vivo model system for type-2 diabetes mellitus?
    Hoppener JW; Oosterwijk C; Verbeek SJ; Van Hulst K; Visser HJ; Hofhuis F; Berends M; Jansz HS; Lips CJ
    Biochem Soc Trans; 1993 Feb; 21(1):28S. PubMed ID: 8449308
    [No Abstract]   [Full Text] [Related]  

  • 33. An in vitro model of early islet amyloid polypeptide (IAPP) fibrillogenesis using human IAPP-transgenic mouse islets.
    Henson MS; Buman BL; Jordan K; Rahrmann EP; Hardy RM; Johnson KH; O'Brien TD
    Amyloid; 2006 Dec; 13(4):250-9. PubMed ID: 17107885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid.
    Butler AE; Janson J; Soeller WC; Butler PC
    Diabetes; 2003 Sep; 52(9):2304-14. PubMed ID: 12941770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Islet amyloid polypeptide in insulinoma and in the islets of the pancreas of non-diabetic and diabetic subjects.
    Toshimori H; Narita R; Nakazato M; Asai J; Mitsukawa T; Kangawa K; Matsuo H; Takahashi K; Matsukura S
    Virchows Arch A Pathol Anat Histopathol; 1991; 418(5):411-7. PubMed ID: 2035254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spontaneous diabetes in hemizygous human amylin transgenic mice that developed neither islet amyloid nor peripheral insulin resistance.
    Wong WP; Scott DW; Chuang CL; Zhang S; Liu H; Ferreira A; Saafi EL; Choong YS; Cooper GJ
    Diabetes; 2008 Oct; 57(10):2737-44. PubMed ID: 18633116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus.
    Hanabusa T; Kubo K; Oki C; Nakano Y; Okai K; Sanke T; Nanjo K
    Diabetes Res Clin Pract; 1992 Jan; 15(1):89-96. PubMed ID: 1541240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophages and pancreatic islet amyloidosis.
    de Koning EJ; van den Brand JJ; Mott VL; Chargé SB; Hansen BC; Bodkin NL; Morris JF; Clark A
    Amyloid; 1998 Dec; 5(4):247-54. PubMed ID: 10036582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus.
    Johnson KH; O'Brien TD; Betsholtz C; Westermark P
    N Engl J Med; 1989 Aug; 321(8):513-8. PubMed ID: 2668761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Islet amyloid and diabetes mellitus type 2].
    Höppener JW; Nieuwenhuis MG; Vroom TM; Lips CJ
    Ned Tijdschr Geneeskd; 2000 Oct; 144(42):1995-2000. PubMed ID: 11072517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.